An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies

被引:1
作者
Montgomery, Hunter [1 ]
Luo, Matthew X. [2 ]
Baker, Steven [3 ]
Lim, Ming Y. [4 ]
机构
[1] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[3] Univ Utah, Med, Salt Lake City, UT USA
[4] Univ Utah, Div Hematol & Hematol Malignancies, Dept Internal Med, Salt Lake City, UT USA
关键词
PATIENT; HYPERHAEMOLYSIS; TOCILIZUMAB;
D O I
10.1155/2023/5290115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Hyperhemolysis syndrome (HS) is a severe hemolytic transfusion reaction that can cause hemoglobin and hematocrit levels to drop below pretransfusion levels, leading to severe anemia. HS most commonly occurs in patients with a pre-existing hemoglobinopathy such as sickle cell disease (SCD) or beta-thalassemia. Methods. We report a case of HS, occurring in the absence of hemoglobinopathy, making the diagnosis challenging. The patient reported was also affected by a CIC-rearranged sarcoma. As part of the workup, the patient received a bone marrow biopsy for suspected hemophagocytic lymphohistiocytosis. Results. This provided a rare biopsy specimen to correlate reticulocytopenia with marked erythroid hyperplasia in the marrow, supporting the hypothesis of reticulocyte destruction as a contributing cause of anemia in these patients. This patient had demonstrable alloantibodies to the Jk(a) and P1 antigens as potential triggers for HS. Conclusions. It is vital that a diagnosis of HS be correctly made in these patients with severe anemia, as blood transfusions generally lead to worsening of their conditions.
引用
收藏
页数:5
相关论文
empty
未找到相关数据